$18.70
al cierre: Nov 10 EDT
$18.70
N/A
Pre-comercialización: 4:00 PM EDT
Avadel Pharmaceuticals emite una orientación sobre las ganancias por acción y los ingresos futuros, lo que ofrece a los inversores una idea de cuánto espera ganar la empresa en los próximos períodos.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
08/07/2025 | AVDL | Avadel Pharmaceuticals | Q3 | 2025 | — | — | — | $71.00M | $75.00M | $70.56M | |
08/07/2025 | AVDL | Avadel Pharmaceuticals | FY | 2025 | — | — | — | $265.00M | $275.00M | $260.18M | |
05/07/2025 | AVDL | Avadel Pharmaceuticals | Q2 | 2025 | — | — | — | $60.00M | $63.00M | $58.21M | |
05/07/2025 | AVDL | Avadel Pharmaceuticals | FY | 2025 | — | — | — | $255.00M | $265.00M | $249.16M | |
03/03/2025 | AVDL | Avadel Pharmaceuticals | FY | 2025 | — | — | — | $240.00M | $260.00M | $250.35M | |
01/08/2025 | AVDL | Avadel Pharmaceuticals | FY | 2024 | — | — | — | $169.00M | $169.00M | $171.41M | |
01/08/2025 | AVDL | Avadel Pharmaceuticals | Q4 | 2024 | — | — | — | $50.00M | $50.00M | $52.70M | |
01/08/2025 | AVDL | Avadel Pharmaceuticals | FY | 2025 | — | — | — | $240.00M | $260.00M | $291.34M |
En los últimos meses no se han comunicado orientaciones específicas de ventas o beneficios para Avadel Pharmaceuticals.
Explora orientación y previsión sobre todos los valores.